Applied Clinical Trials
Current trends in oncology trial terminations as analyzed by Citeline have revealed that sponsors are learning from the past and making gains in this troubled area of drug development.
Christine Blazynski, Ph.D.
Advertisement
Senior Vice-President, Product Development Citeline
Articles by Christine Blazynski, Ph.D.
Advertisement
Latest Updated Articles
Trends in Oncology Trial Terminations: Industry Lessons LearnedAugust 23rd 2012
- Hidden Successes of Oncology Trial Terminations
October 1st 2012
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Reportedly Pauses Commissioner’s National Priority Voucher Pilot as Existing Reviews Continue
2
ACT Brief: Zip Code Trial Access, Smaller Biotech APAC Perceptions, and Pimjetmi Tumor Approval
3
How Inconsistent Screening Shapes Which Oncology Patients Get Flagged for Trials
4
Continuous Glucose Monitoring in Diabetes Clinical Trials: Endpoints, Regulatory Guidance, and Operational Best Practices
5